Oruka Therapeutics, Inc. ORKA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$116.25M+25.3% | -$105.43M+25.6% | -$159.57M-170% | -$157.92M-396% | -$155.59M-1,306% | ||
| $110K+93.0% | $83K+88.6% | $82K+310% | $73K+462% | $57K+307% | ||
| $26.33M-13.2% | $24.24M-5.1% | $35.04M+226% | $34.65M+2,918% | $30.34M+5,251% | ||
| -$90.92M+29.5% | -$88.21M+18.5% | -$123.45M-140% | -$140.87M-900% | -$128.93M-3,494% | ||
| $269K— | $209K— | $335K— | $407K— | —— | ||
| -$154.05M+46.4% | -$96.75M+70.7% | -$404.85M— | -$282.57M— | -$287.43M— | ||
| —— | —— | —— | —— | —— | ||
| -$34.05M-107% | -$14.64M-103% | $91.25M-78.4% | $476.27M+4,282% | $509.57M+10,401% | ||
| -$91.19M— | -$88.42M— | -$123.79M— | -$141.28M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oruka Therapeutics, Inc. generate?
- Oruka Therapeutics, Inc. (ORKA) generated -$90.9M in operating cash flow over the trailing twelve months.
- What is Oruka Therapeutics, Inc.'s free cash flow?
- After $269.0K of capital expenditures, Oruka Therapeutics, Inc.'s free cash flow was -$91.2M over the trailing twelve months, up 23.6% year over year.
- Where does Oruka Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.